Indian Council of Medical Research (ICMR) has asserted that it is acting in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential. It said, it is important to promote indigenous vaccine development while ensuring safety, quality, ethics and adherence to all regulatory requirement. <br />'' <br />''ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called Covaxin. The Drugs Controller General of India has accorded permission to conduct phase-1 and 2 human clinical trial.<br />'' <br />''<span style="color: #222222;">ICMR said, in the larger public health interest, it is important for ICMR to expedite the clinical trials with a promising indigenous vaccine.</span><br />